Clinical Trial Update: Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing [Phase 1]

View source ↗

Summary

This Phase 1 study from Allergy Therapeutics assesses the residual allergenicity of a Grass/Rye Pollen Allergoid using skin prick testing in individuals with Ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• Grass/Rye Pollen Allergoid (Grass and Rye Pollen allergoid)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 1 | Status: COMPLETED